A tractor-trailer crash early Wednesday led to lane reductions and periodic road closures along U.S. Route 2 in Gilead, ...

AbbVie and Gilead Sciences each used the holiday season to reward their pipelines with a new clinical-stage cancer drug. | ...

Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best affordable healthcare stocks to buy now. Gilead Sciences, Inc. (NASDAQ ...

Gilead Sciences, Inc. (NASDAQ:GILD) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. On December 19, ...

Two years after Gilead Sciences secured the first option on Assembly Biosciences’ entire pipeline, the pharma has decided to ...

Gilead Sciences’ chief medical officer will leave the company early next year as the drugmaker struggles to find new areas of growth beyond its core portfolio of HIV medicines. Merdad Parsey, who ...

A tractor-trailer driver crashed in Gilead, Maine, on Wednesday morning when he lost control on an icy road. Mark Keddy of ...

In the latest trading session, Gilead Sciences (GILD) closed at $123.18, marking a -1.38% move from the previous day.

Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Keeley Wettan will be appointed Executive Vice President, General ...

Gilead Sciences has signed an agreement to acquire Repare Therapeutics’ polymerase theta (Polθ) ATPase inhibitor, RP-3467.

Keeley Wettan is succeeding Deborah Telman, who stepped down in November for reasons the company didn't explain.

Gilead CEO Daniel O’Day saw another rise in his pay in 2024, reflecting the steadily upward trajectory of the company since he took the reins in 2019. O’Day received a compensation package of $23.7 ...